mounjaro tirzepatide eli lilly launches weight-loss drug in India, beats Novo Nordisk to major market U.K. to limit Eli Lilly
Description
Importantly, weight loss may restore ovulatory function and fertility in some women with obesity-related menstrual irregularities or PCOS, which has implications for both sexual health and contraception planning

Decrease appetite by delaying gastric emptying and reducing intestinal motility

Penagini, F

These actions work together in a complementary way

The present review has several notable strengths

RELATED: Realities of life on GLP-1s for weight loss: What doctors say you can expect Our Sources Interview with Kirk Habegger, a professor of endocrinology, diabetes and metabolism at The University of Alabama at Birmingham, June 29, 2026 Interview with Arthur Caplan, a retired professor in the Division of Medical Ethics at the NYU Grossman School of Medicine, June 29, 2026 Interview with Sean Turbeville, a biotechnology executive and creator of the regulatory resource the Global Guide to Compassionate Use Programs, June 29, 2026 Eli Lilly, What to know about retatrutide: An investigational triple hormone receptor agonist , June 6, 2026 STAT, Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient